Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

NPY antagonists from Thomae

July 25, 1997

Phosphodiesterase inhibitors from Schering-Plough

July 24, 1997

NPY antagonists developed at Thomae

July 24, 1997

New alinidine analogues described

July 24, 1997

Teva's generic antihypertensive combination tentatively approved

July 23, 1997

Takeda's Atacand scheduled for European launch later this year

July 22, 1997

Low-dose diuretic prevents heart failure in the elderly

July 21, 1997

Selective 15-LO inhibitor effective in animal model of atherosclerosis

July 18, 1997

Orally active ET antagonist from BMS in clinical trials

July 18, 1997

Nippon Shinyaku reveals new series of carboxylic acid derivatives

July 18, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...